Korea vs Spain: Proportion of isolates with decreased susceptibility or resistance
Korea
0
in 2018
Spain
0
in 2020
Korea rank
13th
Spain rank
13th
Proportion of isolates with decreased susceptibility or resistance over time
- Korea
- Spain
How they compare
Korea currently reports 0 against 0 in Spain, a difference of 0.
The two have swapped places 1 time across 8 shared years of data; in 2009 it was Korea ahead.
Korea ranks 13th and Spain ranks 13th of 52 countries.
Korea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Korea | Spain | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 29.27 | 0 | 29.27 | Korea |
| 2010s | 16.65 | 0.8774 | 15.77 | Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Korea or Spain?
- Korea, at 0 against 0 in Spain as of 2018.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Korea and Spain?
- 0, with Korea ahead.
- How many years of comparable data are there for Korea and Spain?
- 8 years are reported by both, from 2009 to 2018.
- How do Korea and Spain rank globally for proportion of isolates with decreased susceptibility or resistance?
- Korea ranks 13th and Spain ranks 13th of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.